BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37833911)

  • 21. Higher Expression of Activated CD8
    Boix F; Jimenez-Coll V; Legaz I; Alfaro R; Moya-Quiles MR; Peña-Moral J; Minguela A; Llorente S; Muro M
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):119. PubMed ID: 37395036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance.
    Sharland A; Yan Y; Wang C; Bowen DG; Sun J; Sheil AG; McCaughan GW; Bishop GA
    Transplantation; 1999 Dec; 68(11):1736-45. PubMed ID: 10609951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient.
    Kusaka S; Grailer AP; Fechner JH; Jankowska-Gan E; Oberley T; Sollinger HW; Burlingham WJ
    J Immunol; 2000 Feb; 164(4):2240-7. PubMed ID: 10657680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells.
    Tanimine N; Burrell BE; Deng K; Rickert C; Lee KM; Feeney N; Pardo J; LeGuern C; Markmann JF
    J Immunol Methods; 2021 Apr; 491():112987. PubMed ID: 33556344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
    Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
    Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates.
    Bestard O; Cruzado JM; Mestre M; Caldés A; Bas J; Carrera M; Torras J; Rama I; Moreso F; Serón D; Grinyó JM
    J Immunol; 2007 Oct; 179(7):4901-9. PubMed ID: 17878390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.
    Abdul Razzaq B; Scalora A; Koparde VN; Meier J; Mahmood M; Salman S; Jameson-Lee M; Serrano MG; Sheth N; Voelkner M; Kobulnicky DJ; Roberts CH; Ferreira-Gonzalez A; Manjili MH; Buck GA; Neale MC; Toor AA
    Biol Blood Marrow Transplant; 2016 May; 22(5):850-61. PubMed ID: 26688192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome.
    Thieme CJ; Weist BJD; Mueskes A; Roch T; Stervbo U; Rosiewicz K; Wehler P; Stein M; Nickel P; Kurtz A; Lachmann N; Choi M; Schmueck-Henneresse M; Westhoff TH; Reinke P; Babel N
    Sci Rep; 2019 Dec; 9(1):19037. PubMed ID: 31836826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
    J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.
    Scheinberg P; Price DA; Ambrozak DR; Barrett AJ; Douek DC
    Exp Hematol; 2006 Jun; 34(6):788-95. PubMed ID: 16728284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of T-cell alloantigen response
    Iwahara N; Hotta K; Iwami D; Tanabe T; Tanaka Y; Ito YM; Otsuka T; Murai S; Takada Y; Higuchi H; Sasaki H; Hirose T; Harada H; Shinohara N
    Front Immunol; 2023; 14():1164794. PubMed ID: 37207202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
    Wehler TC; Nonn M; Brandt B; Britten CM; Gröne M; Todorova M; Link I; Khan SA; Meyer RG; Huber C; Hartwig UF; Herr W
    Blood; 2007 Jan; 109(1):365-73. PubMed ID: 16931626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
    Mittal SK; Sharma RK; Gupta A; Naik S
    Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
    Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
    J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of Sensitization Status in Renal Transplant Recipients by Assessing Indirect Pathway CD4 + T Cell Response to Donor Cell-pulsed Dendritic Cell.
    Kenta I; Toshihide T; Takashi S; Shintaro S; Yuko M; Manabu O; Takahisa H; Norihiko G; Shunji N; Yoshihiko W; Mai O; Satoshi A; Kohei I; Ezzelarab MB; Takaaki K
    Transplantation; 2023 May; 107(5):1079-1088. PubMed ID: 36814087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.
    Savage TM; Shonts BA; Obradovic A; Dewolf S; Lau S; Zuber J; Simpson MT; Berglund E; Fu J; Yang S; Ho SH; Tang Q; Turka LA; Shen Y; Sykes M
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.